Works matching AU Yakubo, Shunta

Results: 3

Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review.
Published in:
2021
By:
- Watanabe, Yusuke;
- Osaki, Akihiko;
- Kimura, Kiwamu;
- Yakubo, Shunta;
- Takaku, Kenichi;
- Sato, Munehiro;
- Hashidate, Hideki;
- Waguri, Nobuo;
- Terai, Shuji
Publication type:
journal article
Balloon‐occluded retrograde transvenous obliteration for gastric varices improves hepatic functional reserve in long‐term follow‐up.
Published in:
JGH Open, 2021, v. 5, n. 12, p. 1328, doi. 10.1002/jgh3.12675
By:
- Waguri, Nobuo;
- Osaki, Akihiko;
- Watanabe, Yusuke;
- Matsubara, Tsuyoshi;
- Yamazaki, Shun;
- Yokoyama, Hanako;
- Kimura, Kiwamu;
- Wakabayashi, Takuya;
- Mito, Masaki;
- Yakubo, Shunta;
- Azumi, Rie;
- Kohisa, Junji;
- Takaku, Kennichi;
- Sato, Munehiro;
- Furukawa, Kouichi
Publication type:
Article
Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model.
Published in:
Diseases, 2024, v. 12, n. 12, p. 317, doi. 10.3390/diseases12120317
By:
- Yakubo, Shunta;
- Abe, Hiroyuki;
- Li, Yawen;
- Kudo, Marina;
- Kimura, Atsushi;
- Wakabayashi, Takuya;
- Watanabe, Yusuke;
- Kimura, Naruhiro;
- Setsu, Toru;
- Yokoo, Takeshi;
- Sakamaki, Akira;
- Kamimura, Hiroteru;
- Tsuchiya, Atsunori;
- Kamimura, Kenya;
- Terai, Shuji
Publication type:
Article

Works matching AU Yakubo, Shunta

Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review.

Balloon‐occluded retrograde transvenous obliteration for gastric varices improves hepatic functional reserve in long‐term follow‐up.

Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease Model.